Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

M LAMBERTINI; F POGGIO; M BRUZZONE; BENEDETTA CONTE; C BIGHIN; AZAMBUJA E DE; M GIULIANO; LAURENTIIS M DE; F COGNETTI; A FABI; G BISAGNI; A DURANDO; A TURLETTI; Y URRACCI; O GARRONE; F PUGLISI; F MONTEMURRO; I M CEPP; MASTRO L DEL

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

M LAMBERTINI
, F POGGIO
, M BRUZZONE
, BENEDETTA CONTE
, C BIGHIN
, AZAMBUJA E DE
, M GIULIANO
, LAURENTIIS M DE
, F COGNETTI
, A FABI
, G BISAGNI
, A DURANDO
, A TURLETTI
, Y URRACCI
, O GARRONE
, F PUGLISI
, F MONTEMURRO
, I M CEPP
, MASTRO L DEL

Department of Translational Medicine

Research output: Contribution to journal › Article

Original language	English
Journal	International Journal of Cancer
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://hdl.handle.net/11579/192946

Cite this

LAMBERTINI, M., POGGIO, F., BRUZZONE, M., CONTE, BENEDETTA., BIGHIN, C., DE, AZAMBUJA. E., GIULIANO, M., DE, LAURENTIIS. M., COGNETTI, F., FABI, A., BISAGNI, G., DURANDO, A., TURLETTI, A., URRACCI, Y., GARRONE, O., PUGLISI, F., MONTEMURRO, F., CEPP, I. M., & DEL, MASTRO. L. (2020). Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. International Journal of Cancer. https://hdl.handle.net/11579/192946

@article{5da7fb93cdf545e3a92187e160d1c150,

title = "Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial",

author = "M LAMBERTINI and F POGGIO and M BRUZZONE and BENEDETTA CONTE and C BIGHIN and DE, \{AZAMBUJA E\} and M GIULIANO and DE, \{LAURENTIIS M\} and F COGNETTI and A FABI and G BISAGNI and A DURANDO and A TURLETTI and Y URRACCI and O GARRONE and F PUGLISI and F MONTEMURRO and CEPP, \{I M\} and DEL, \{MASTRO L\}",

year = "2020",

language = "English",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

}

LAMBERTINI, M, POGGIO, F, BRUZZONE, M, CONTE, BENEDETTA, BIGHIN, C, DE, AZAMBUJAE, GIULIANO, M, DE, LAURENTIISM, COGNETTI, F, FABI, A, BISAGNI, G, DURANDO, A, TURLETTI, A, URRACCI, Y, GARRONE, O, PUGLISI, F, MONTEMURRO, F, CEPP, IM & DEL, MASTROL 2020, 'Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial', International Journal of Cancer. <https://hdl.handle.net/11579/192946>

TY - JOUR

T1 - Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

AU - LAMBERTINI, M

AU - POGGIO, F

AU - BRUZZONE, M

AU - CONTE, BENEDETTA

AU - BIGHIN, C

AU - DE, AZAMBUJA E

AU - GIULIANO, M

AU - DE, LAURENTIIS M

AU - COGNETTI, F

AU - FABI, A

AU - BISAGNI, G

AU - DURANDO, A

AU - TURLETTI, A

AU - URRACCI, Y

AU - GARRONE, O

AU - PUGLISI, F

AU - MONTEMURRO, F

AU - CEPP, I M

AU - DEL, MASTRO L

PY - 2020

Y1 - 2020

UR - https://iris.uniupo.it/handle/11579/192946

M3 - Article

SN - 0020-7136

JO - International Journal of Cancer

JF - International Journal of Cancer

ER -

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial

UN SDGs

Access to Document

Other files and links

Cite this